Headache Study to Compare Aggrenox Full Dose and Reduced Dose

Clinical trial NCT00274586 · COMPLETED

Trial details

NCT number: NCT00274586
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cerebrovascular Accident

Start date: 2002-09-01
Primary completion: 2003-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.